Literature DB >> 25660217

OFSEP, a nationwide cohort of people with multiple sclerosis: Consensus minimal MRI protocol.

F Cotton1, S Kremer2, S Hannoun3, S Vukusic4, V Dousset5.   

Abstract

Multiple sclerosis (MS) is most generally considered as a severe disease with high physical and mental risks of disability. Since the end of the 1990s, several high cost long-term disease-modifying treatments provided some clinical efficiency. However, patient's follow-up was needed for the detection and the assessment of their side-effects. The "Observatoire français de la sclérose en plaques" (OFSEP) project aims to improve the clinical, biological and imaging systematic longitudinal follow-up of patients. It should increase the quality, efficiency and safety of patients' care, with a unique opportunity of large scale, about 41,000 patients followed in 62 French centers using the European Database for Multiple Sclerosis (EDMUS) software. OFSEP is divided into three working groups (clinical, biological and imaging). The imaging working group defines standards for routine MRI follow-up in the whole cohort and contains three subgroups: acquisition, workflow, and data processing. A common and feasible brain and spinal cord acquisition protocol has been defined by the acquisition group, and accepted by the OFSEP steering and scientific committees. This protocol can be implemented in all French MRI centers. The major MRI manufacturers have agreed to provide the dedicated collection of sequences as an "OFSEP box" with every software upgrade or new MRI machine. The new OFSEP protocol will provide a unique opportunity to study a population-based collection of data from people with MS.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cohort studies; Consensus development conferences as topic; Magnetic resonance imaging; Multiple sclerosis

Mesh:

Year:  2015        PMID: 25660217     DOI: 10.1016/j.neurad.2014.12.001

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  17 in total

1.  Improving Detection of Multiple Sclerosis Lesions in the Posterior Fossa Using an Optimized 3D-FLAIR Sequence at 3T.

Authors:  A Lecler; I El Sanharawi; J El Methni; O Gout; P Koskas; J Savatovsky
Journal:  AJNR Am J Neuroradiol       Date:  2019-06-27       Impact factor: 3.825

2.  Digital biomarkers can highlight subtle clinical differences in radiologically isolated syndrome compared to healthy controls.

Authors:  Mikael Cohen; Lydiane Mondot; Salim Fakir; Cassandre Landes; Christine Lebrun
Journal:  J Neurol       Date:  2020-10-19       Impact factor: 4.849

3.  A hybrid approach based on logistic classification and iterative contrast enhancement algorithm for hyperintense multiple sclerosis lesion segmentation.

Authors:  Antonio Carlos da Silva Senra Filho
Journal:  Med Biol Eng Comput       Date:  2017-11-18       Impact factor: 2.602

4.  Gadolinium effect on thalamus and whole brain tissue segmentation.

Authors:  Salem Hannoun; Marwa Baalbaki; Ribal Haddad; Stephanie Saaybi; Nabil K El Ayoubi; Bassem I Yamout; Samia J Khoury; Roula Hourani
Journal:  Neuroradiology       Date:  2018-08-21       Impact factor: 2.804

5.  Early B cells repopulation in multiple sclerosis patients treated with rituximab is not predictive of a risk of relapse or clinical progression.

Authors:  Guillaume Dorcet; Hugo Migné; Damien Biotti; Chloé Bost; Fleur Lerebours; Jonathan Ciron; Emmanuel Treiner
Journal:  J Neurol       Date:  2022-06-02       Impact factor: 6.682

6.  Objective Evaluation of Multiple Sclerosis Lesion Segmentation using a Data Management and Processing Infrastructure.

Authors:  Olivier Commowick; Audrey Istace; Michaël Kain; Baptiste Laurent; Florent Leray; Mathieu Simon; Sorina Camarasu Pop; Pascal Girard; Roxana Améli; Jean-Christophe Ferré; Anne Kerbrat; Thomas Tourdias; Frédéric Cervenansky; Tristan Glatard; Jérémy Beaumont; Senan Doyle; Florence Forbes; Jesse Knight; April Khademi; Amirreza Mahbod; Chunliang Wang; Richard McKinley; Franca Wagner; John Muschelli; Elizabeth Sweeney; Eloy Roura; Xavier Lladó; Michel M Santos; Wellington P Santos; Abel G Silva-Filho; Xavier Tomas-Fernandez; Hélène Urien; Isabelle Bloch; Sergi Valverde; Mariano Cabezas; Francisco Javier Vera-Olmos; Norberto Malpica; Charles Guttmann; Sandra Vukusic; Gilles Edan; Michel Dojat; Martin Styner; Simon K Warfield; François Cotton; Christian Barillot
Journal:  Sci Rep       Date:  2018-09-12       Impact factor: 4.379

7.  Graph Theory-Based Brain Connectivity for Automatic Classification of Multiple Sclerosis Clinical Courses.

Authors:  Gabriel Kocevar; Claudio Stamile; Salem Hannoun; François Cotton; Sandra Vukusic; Françoise Durand-Dubief; Dominique Sappey-Marinier
Journal:  Front Neurosci       Date:  2016-10-25       Impact factor: 4.677

Review 8.  Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society.

Authors:  M Vågberg; M Axelsson; R Birgander; J Burman; C Cananau; Y Forslin; T Granberg; M Gunnarsson; A von Heijne; L Jönsson; V D Karrenbauer; E-M Larsson; T Lindqvist; J Lycke; L Lönn; E Mentesidou; S Müller; P Nilsson; F Piehl; A Svenningsson; M Vrethem; J Wikström
Journal:  Acta Neurol Scand       Date:  2016-08-24       Impact factor: 3.209

9.  Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies.

Authors:  Elisabeth Maillart; Françoise Durand-Dubief; Céline Louapre; Bertrand Audoin; Bertrand Bourre; Nathalie Derache; Jonathan Ciron; Nicolas Collongues; Jérome de Sèze; Mikael Cohen; Christine Lebrun-Frenay; Nawel Hadhoum; Hélène Zéphir; Romain Deschamps; Clarisse Carra-Dallière; Pierre Labauge; Philippe Kerschen; Alexis Montcuquet; Sandrine Wiertlewski; David Laplaud; Gwenaëlle Runavot; Sandra Vukusic; Caroline Papeix; Romain Marignier
Journal:  J Neuroinflammation       Date:  2020-04-23       Impact factor: 8.322

10.  Socio-economic status influences access to second-line disease modifying treatment in Relapsing Remitting Multiple Sclerosis patients.

Authors:  Floriane Calocer; Olivier Dejardin; Karine Droulon; Guy Launoy; Gilles Defer
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.